SEC Form 4 · accession 0000905718-19-000106
Matinas BioPharma Holdings, Inc. · MTNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Herbert J Conrad
Director
Period of report
Feb 8, 2019
Accepted (ET)
Feb 12, 2019 · 5:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001582554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 8, 2019 | G | 3,932,903 | $0.00 | D | 100,000 | D | |
| Common Stock | holding | — | — | — | 3,932,903 | I | By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad and Judith Conrad, Trustees |
Table II — derivative securities
No Table II lines on this filing.